EP 0735878 A1 19961009 - PHARMACEUTICALS
Title (en)
PHARMACEUTICALS
Title (de)
PHARMAZEUTIKA
Title (fr)
PRODUITS PHARMACEUTIQUES
Publication
Application
Priority
- EP 9404163 W 19941214
- GB 9326177 A 19931222
Abstract (en)
[origin: WO9517190A1] A method for the treatment (including prophylaxis) of ZAP in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A) or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing and the use of a compound of formula (A): or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing in the manufacture of a medicament for use in the treatment (including prophylaxis) of ZAP.
IPC 1-7
IPC 8 full level
C07D 473/18 (2006.01); A61K 31/52 (2006.01); A61K 31/522 (2006.01); A61P 31/12 (2006.01); C07D 473/00 (2006.01)
CPC (source: EP)
A61K 31/52 (2013.01); A61P 19/00 (2017.12); A61P 31/12 (2017.12); A61P 31/22 (2017.12); C07D 473/00 (2013.01)
Citation (search report)
See references of WO 9517190A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9517190 A1 19950629; AU 1383495 A 19950710; AU 697290 B2 19981001; CA 2179282 A1 19950629; CN 1084622 C 20020515; CN 1142769 A 19970212; EP 0735878 A1 19961009; GB 9326177 D0 19940223; JP H09506883 A 19970708; ZA 9410113 B 19950825
DOCDB simple family (application)
EP 9404163 W 19941214; AU 1383495 A 19941214; CA 2179282 A 19941214; CN 94194994 A 19941214; EP 95905068 A 19941214; GB 9326177 A 19931222; JP 51715795 A 19941214; ZA 9410113 A 19941220